Self-reported reasons for medical and nonmedical cannabis use in Australia: A cross-sectional analysis of the International Cannabis Policy Study 2023.
Self-reported reasons for medical and nonmedical cannabis use in Australia: A cross-sectional analysis of the International Cannabis Policy Study 2023.
Australian cross-sectional survey reveals dual-use cannabis patterns, with medical-only users comprising just 1.9% of population while 5.0% report concurrent medical and recreational use.
This population-level survey demonstrates that pure medical cannabis use represents a small fraction of overall cannabis consumption in Australia, while dual-use patterns are more than twice as common. The data provides baseline prevalence estimates for different use patterns following Australia’s medical cannabis legalization framework.
These findings challenge assumptions about medical cannabis program utilization and highlight the complexity of patient motivations. Clinicians need to understand that patients may have mixed motivations for cannabis use, which could influence treatment planning and regulatory compliance discussions.
| Study Type | Cross-sectional Survey |
| Population | Australian adults, n=3042, from 2023 International Cannabis Policy Study |
| Intervention | Self-reported cannabis use patterns and medical indications |
| Comparator | Medical-only vs recreational-only vs dual-use vs no use |
| Primary Outcome | Proportions of different cannabis use motives and medical conditions treated |
| Key Finding | 86.3% no use, 1.9% medical-only, 6.7% recreational-only, 5.0% dual-use |
| Journal | Drug and Alcohol Dependence |
| Year | 2023 |
Medical-only cannabis use remains uncommon in the general Australian population, while dual-use patterns are prevalent among medical cannabis users. This suggests patient counseling should address the intersection of medical treatment goals and recreational use preferences.
The study cannot establish causation, validate self-reported medical indications against clinical diagnoses, or determine treatment efficacy. Cross-sectional design prevents understanding of how use patterns change over time or whether medical use leads to recreational use or vice versa.
Self-reported data may suffer from social desirability bias and recall errors. The survey methodology cannot verify actual medical cannabis prescriptions or distinguish between legal medical access and self-medication. Response bias may affect representativeness of cannabis users.
Cannabis use patterns are more nuanced than regulatory frameworks suggest, with dual-use being common among medical users. Population-level surveys provide valuable context for clinical practice but cannot substitute for individual patient assessment and clinical validation of medical indications.
Join the Conversation
Have a question about how this applies to your situation? Ask Dr. Caplan →
Want to discuss this topic with other patients and caregivers? Join the forum discussion →
Have thoughts on this? Share it:
FAQ
What proportion of Australian adults use cannabis for medical purposes only?
According to this 2023 study, only 1.9% of Australian adults reported using cannabis for medical purposes exclusively. This represents a relatively small portion of the population, with the majority (86.3%) reporting no cannabis use at all.
How common is dual-use of cannabis for both medical and recreational purposes?
The study found that 5.0% of Australian adults engage in dual-use, meaning they use cannabis for both medical and recreational reasons concurrently. This dual-use pattern is actually more prevalent than medical-only use (1.9%), suggesting overlapping motivations for cannabis consumption.
Should clinicians be concerned about patients using cannabis for both medical and recreational purposes?
Yes, dual-use patterns warrant clinical attention as they may complicate treatment monitoring, dosing protocols, and assessment of therapeutic outcomes. Clinicians should inquire about all cannabis use patterns to ensure appropriate medical oversight and optimize therapeutic benefits while minimizing potential risks.
What does this study tell us about the current state of Australia’s medicinal cannabis framework?
The study reveals that despite increasing commercialization of Australia’s medicinal cannabis framework, pure medical use remains limited at just 1.9% of the population. The higher prevalence of dual-use (5.0%) compared to medical-only use suggests patients may be supplementing or combining formal medical cannabis with recreational sources.
How should healthcare providers approach cannabis use discussions with patients?
Healthcare providers should routinely ask patients about all forms of cannabis use, not just medical use, given that dual-use is more common than medical-only use. Open, non-judgmental discussions about cannabis use patterns can help optimize therapeutic outcomes and ensure appropriate clinical monitoring of patients using cannabis for health conditions.
